Trial intelligence / Profile preview

Vitamin D3 8400IU in elderly with low vitamin D

NCT00242476Phase 2Completed

Sponsor
Merck & Co.
Start
Sep 2005
Primary completion
Jul 2006
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 2 trial of cholecalciferol in Vitamin D deficiency (VDD), sponsored by Merck & Co.. Started Sep 2005; status: completed.

02

Drugs

cholecalciferol
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT00242476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00242476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call